Sean L. Kitson, Stuart Jones, William Watters, Fiona Chan and David Madge, (2010): Labelled Compounds and Radiopharmaceuticals

Malik, M., Hnatkova, K., Ford, J. and Madge, D. (2008): Journal of Clinical Pharmacology; 48, 1146-1157

Ford, JW. and Milnes, JT., (2008): J Cardiovasc Pharmacol; 52, 105-120

Willett, P., Wilton, D., Hartzoulakis, B., Tang, R., Ford, J. and Madge, D., (2007): J. Chem. Inf. Model; 47, 1961-1966.

Biophysical characterization of duloxetine activity on voltage-gated sodium channels involved in pain transmission

Development of a hKv1.3 ion channel screening assay using the QPatch 16 automated patch-clamp platform

The Atrial Antiarrhythmic Drug XEN-D0101 Selectively Inhibits the Human Ultra-Rapid Delayed-Rectifier Potassium Current (IKur) Over Other Cardiac Ion Channels

Targeting the hKv1.3 potassium channel in the development of novel treatments for autoimmune diseases

State-Dependent Inhibitors of the Nav1.3 Sodium Channel for Treating Neuropathic Pain

Targeting the Nav1.3 Sodium Channel in the Development of Novel Treatments for Neuropathic Pain

A comparison of the effects of known Ion Channel Modulators against A K+ current recorded using autopatch & ‘conventional’ Ion Channel Screening technologies